Livzon Pharmaceutical Group Overview

  • Founded
  • 1985
Founded
  • Status
  • Public
  • Employees
  • 8,020
Employees
  • Stock Symbol
  • 000513
Stock Symbol
  • Investments
  • 8
  • Share Price
  • $5.82
  • (As of Friday Closing)

Livzon Pharmaceutical Group General Information

Description

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises of western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drugs address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system and other conditions. The Company distributes its products within domestic market and to overseas markets. The company operates in a single reportable segment that is pharmaceutical manufacturing.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Primary Office
  • No.132, Guihua Road North
  • Gongbei, Zhuhai
  • Guangdong, 519020
  • China
+86 175 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Livzon Pharmaceutical Group Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.82 $5.82 $4.72 - $8.97 $4.77B 939M 7.45M $0.26

Livzon Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,162,965 3,093,834 1,601,241 4,243,782
Revenue 1,428,304 1,358,203 1,339,423 1,262,360
EBITDA 325,317 273,962 236,025 889,184
Net Income 240,242 188,559 163,587 655,330
Total Assets 2,830,178 2,569,241 2,534,867 2,435,057
Total Debt 215,467 194,495 218,215 168
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Livzon Pharmaceutical Group Executive Team (1)

Name Title Board Seat Contact Info
YuCai Peng Ph.D Vice President, Research & Technical Development
To view Livzon Pharmaceutical Group’s complete executive team members history, request access »

Livzon Pharmaceutical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Livzon Pharmaceutical Group Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 01-Mar-2021 00000 00000 00 0000 Drug Discovery
00000000 000000000 05-Feb-2021 00000 00000 00 Drug Discovery
0000 0000000000 27-May-2020 00000 00000 00 0000 Drug Discovery
0000 0000000000 17-Jan-2020 00000 00000 00 000.00 Drug Discovery
Elicio Therapeutics 02-Oct-2019 Later Stage VC 000.00 Drug Discovery
You’re viewing 5 of 8 investments. Get the full list »

Livzon Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000 Drug Discovery Zhuhai, China 0000
To view Livzon Pharmaceutical Group’s complete subsidiaries history, request access »

Livzon Pharmaceutical Group Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 16-Apr-2014 00000 00000 00 0000 Completed
  • 11 buyers
To view Livzon Pharmaceutical Group’s complete exits history, request access »